Premium
O1‐06‐02: Clusterin is a Plasma Biomarker of Severity, Progression and Pathology in Alzheimer's Disease
Author(s) -
Thambisetty Madhav,
Resnick Susan M.,
Ferrucci Luigi,
Wong Dean,
Zhou Yun
Publication year - 2009
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2009.07.120
Subject(s) - clusterin , biomarker , alzheimer's disease neuroimaging initiative , atrophy , disease , oncology , alzheimer's disease , cohort , cognitive decline , medicine , proteome , neuroimaging , pathology , psychology , dementia , bioinformatics , neuroscience , biology , biochemistry , apoptosis
552-5260/09/ DETERMINE INHERITANCE OF ALZHEIMER’S DISEASE INDEPENDENTLY OF APOEe4 RISK Allen D. Roses, Michael W. Lutz, Matthew J. Huentelman, Ornit Chiba-Falek, Kathleen A. Welsh-Bohmer, Eric M. Reiman, Duke University, Durham, NC, USA; Deane Drug Discovery Institute, Durham, NC, USA; Translational Genomics Research Institute, Phoenix, AZ, USA; University of Arizona, Phoenix, AZ, USA; Institute for Genomic Sciences and Policy, Durham, NC, USA; Alzheimer’s Disease Clinical Center, Durham, NC, USA; Banner Alzheimer’s Institute, Phoenix, AZ, USA